Predicting Avatrombopag response in children with immune thrombocytopenia: A multi-view learning framework for tabular missing data
{{output}}
Background and objective: Avatrombopag is a thrombopoietin receptor agonist that has demonstrated clinical efficacy in rapidly increasing platelet counts and achieving bleeding control in children with chronic immune thrombocytop... ...
